
Penride MP 1mg/500mg/15mg Tablet SR
Marketer
Penryth Labs Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Penride MP 1mg/500mg/15mg Tablet SR
Glycemia-Control SR tablets (1mg/500mg/15mg) combine medications to manage blood glucose. In adults with type 2 diabetes, this formulation, used alongside diet and exercise, enhances blood sugar regulation by improving insulin effectiveness. Dosage and duration should strictly follow your physician's instructions. Administer with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in such cases, omit the missed dose. Never double the dose; overdose risks hypoglycemia. Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation. Kidney function tests will be performed before treatment initiation. Limit alcohol consumption to mitigate potential side effect intensification.
Uses of Penride MP 1mg/500mg/15mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Penride MP 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Penride MP 1mg/500mg/15mg Extended-Release Tablets with food.
Common Side effects of Penride MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Penride MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Penride MP 1mg/500mg/15mg Extended-Release Tablets should be administered with food.
How Penride MP 1mg/500mg/15mg Tablet SR works:
Penride MP 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple therapy enhances blood sugar management when monotherapy or dual combinations prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further boosts insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Penride MP 1mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Penride MP 1mg/500mg/15mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Penride MP tablet (1mg/500mg/15mg) is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Penride MP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Penride MP 1mg/500mg/15mg SR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Penride MP 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Penride MP 1mg/500mg/15mg Tablet SR is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Penride MP 1mg/500mg/15mg Tablet SR :
Should you forget a Penride MP 1mg/500mg/15mg Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Penride MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
